The DOI matches its Crossref record; 162 of the 162 references it cites were found in a registry or an index.
Guidelines for the welfare and use of animals in cancer research
Open accessAbstract
Animal experiments remain essential to understand the fundamental mechanisms underpinning malignancy and to discover improved methods to prevent, diagnose and treat cancer. Excellent standards of animal care are fully consistent with the conduct of high quality cancer research. Here we provide updated guidelines on the welfare and use of animals in cancer research. All experiments should incorporate the 3Rs: replacement, reduction and refinement. Focusing on animal welfare, we present recommendations on all aspects of cancer research, including: study design, statistics and pilot studies; choice of tumour models (e.g., genetically engineered, orthotopic and metastatic); therapy (including drugs and radiation); imaging (covering techniques, anaesthesia and restraint); humane endpoints (including tumour burden and site); and publication of best practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Chou, T.-C. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.10 · Cited by 5,163
The Principles of Humane Experimental Technique
(1960) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1960.tb73127.x · Cited by 4,912
Cancer genes and the pathways they control
Vogelstein, B., & Kinzler, K. W. (2004) · Nature Medicine · doi:10.1038/nm1087 · Cited by 4,249
Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
Stratton, M. R., Campbell, P. J., & Futreal, P. A. (2009) · Nature · doi:10.1038/nature07943 · Cited by 3,449
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., Richardson, A. L., Polyak, K., Tubo, R., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06188 · Cited by 3,206
Metastasis: from dissemination to organ-specific colonization
Nguyen, D. X., Bos, P. D., & Massagué, J. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2622 · Cited by 2,649
Hingorani, S. R., Wang, L., Multani, A. S., Combs, C., Deramaudt, T. B., Hruban, R. H., Rustgi, A. K., Chang, S., & Tuveson, D. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.023 · Cited by 2,609
Imaging in the era of molecular oncology
Weissleder, R., & Pittet, M. J. (2008) · Nature · doi:10.1038/nature06917 · Cited by 2,364
Clinical pharmacokinetics; concepts and applications
(1989) · General Pharmacology: The Vascular System · doi:10.1016/0306-3623(89)90348-0 · Cited by 2,223
Guy, C. T., Cardiff, R. D., & Muller, W. J. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.3.954 · Cited by 1,631
Diehl, K., Hull, R., Morton, D., Pfister, R., Rabemampianina, Y., Smith, D., Vidal, J., & Vorstenbosch, C. V. D. (2001) · Journal of Applied Toxicology · doi:10.1002/jat.727 · Cited by 1,562
Artursson, P., Palm, K., & Luthman, K. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00128-9 · Cited by 1,543
Freireich, E. J., Gehan, E. A., Rall, D. P., Schmidt, L. H., & Skipper, H. E. (1966) · PubMed · Cited by 1,382
Somatic activation of the K-ras oncogene causes early onset lung cancer in mice
Johnson, L., Mercer, K., Greenbaum, D., Bronson, R. T., Crowley, D., Tuveson, D. A., & Jacks, T. (2001) · Nature · doi:10.1038/35074129 · Cited by 1,179
Sawyers, C. (2004) · Nature · doi:10.1038/nature03095 · Cited by 1,165
Guidelines for the Design and Statistical Analysis of Experiments Using Laboratory Animals
Festing, M. F. W., & Altman, D. G. (2002) · ILAR Journal · doi:10.1093/ilar.43.4.244 · Cited by 1,110
Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice
Artandi, S. E., Chang, S., Lee, S.-L., Alson, S., Gottlieb, G. J., Chin, L., & DePinho, R. A. (2000) · Nature · doi:10.1038/35020592 · Cited by 1,085
Jonkers, J., Meuwissen, R., van der Gulden, H., Peterse, H., van der Valk, M., & Berns, A. (2001) · Nature Genetics · doi:10.1038/ng747 · Cited by 1,053
Aguirre, A. J., Bardeesy, N., Sinha, M., Lopez, L., Tuveson, D. A., Horner, J., Redston, M. S., & DePinho, R. A. (2003) · Genes & Development · doi:10.1101/gad.1158703 · Cited by 1,033 · cited 1×
“…K-rasG12D+Ink4a/Arf deficiency or combined withTrp53R172H Metastatic lung cancer Metastatic pancreatic cancer (Johnson et al, 2001) (Aguirre et al, 2003; Hingorani et al, 2005) AML1/ETO or MLL fusion proteins AML AML (Zuber et al, 2009) MYCN Neuroblastoma, Rhabdomyosarcoma,…”
BackgroundEffects of Angiogenesis Inhibitors on Multistage Carcinogenesis in Mice
Bergers, G., Javaherian, K., Lo, K.-M., Folkman, J., & Hanahan, D. (1999) · Science · doi:10.1126/science.284.5415.808 · Cited by 988 · cited 1×
“…Trp53-knockout crosses (Wetmore et al, 2001) T-antigen Pancreatic adenocarcinoma RIP1-Tag2 driven overexpression in pancreatic islets (Bergers et al, 1999) PTEN Breast, endometrial, glioblastoma, prostate, and thyroid carcinoma, Cowden syndrome, hamartomas, urothelial tumours of…”
BackgroundIntravital imaging of cell movement in tumours
Condeelis, J., & Segall, J. E. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1231 · Cited by 929
Reversible Tumorigenesis by MYC in Hematopoietic Lineages
Felsher, D. W., & Bishop, J. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80367-6 · Cited by 881
Targeted expression of MYCN causes neuroblastoma in transgenic mice
Weiss, W. A. (1997) · The EMBO Journal · doi:10.1093/emboj/16.11.2985 · Cited by 870
Modelling Myc inhibition as a cancer therapy
Soucek, L., Whitfield, J., Martins, C. P., Finch, A. J., Murphy, D. J., Sodir, N. M., Karnezis, A. N., Swigart, L. B., Nasi, S., & Evan, G. I. (2008) · Nature · doi:10.1038/nature07260 · Cited by 817
Spaeth, E. L., Dembinski, J. L., Sasser, A. K., Watson, K., Klopp, A., Hall, B., Andreeff, M., & Marini, F. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004992 · Cited by 807
Sinn, E., Muller, W., Pattengale, P., Tepler, I., Wallace, R., & Leder, P. (1987) · Cell · doi:10.1016/0092-8674(87)90449-1 · Cited by 792
Xu, X., Wagner, K.-U., Larson, D., Weaver, Z., Li, C., Ried, T., Hennighausen, L., Wynshaw-Boris, A., & Deng, C.-X. (1999) · Nature Genetics · doi:10.1038/8743 · Cited by 758
Maximizing mouse cancer models
Frese, K. K., & Tuveson, D. A. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2192 · Cited by 717
Signatures of mutation and selection in the cancer genome
Bignell, G. R., Greenman, C. D., Davies, H., Butler, A. P., Edkins, S., Andrews, J. M., Buck, G., Chen, L., Beare, D., Latimer, C., et al. (2010) · Nature · doi:10.1038/nature08768 · Cited by 707
The mighty mouse: genetically engineered mouse models in cancer drug development
Sharpless, N. E., & DePinho, R. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2110 · Cited by 661
Mannhold, R., Poda, G. I., Ostermann, C., & Tetko, I. V. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21494 · Cited by 654
The multiple uses of fluorescent proteins to visualize cancer in vivo
Hoffman, R. M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1717 · Cited by 617
Brown, E. B., Campbell, R. B., Tsuzuki, Y., Xu, L., Carmeliet, P., Fukumura, D., & Jain, R. K. (2001) · Nature Medicine · doi:10.1038/89997 · Cited by 605
Rapid Colorectal Adenoma Formation Initiated by Conditional Targeting of the Apc Gene
Shibata, H., Toyama, K., Shioya, H., Ito, M., Hirota, M., Hasegawa, S., Matsumoto, H., Takano, H., Akiyama, T., Toyoshima, K., et al. (1997) · Science · doi:10.1126/science.278.5335.120 · Cited by 605
Body condition scoring: a rapid and accurate method for assessing health status in mice.
Ullman-Culleré, M., & Foltz, C. J. (1999) · PubMed · Cited by 572
Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice
Krimpenfort, P., Quon, K. C., Mooi, W. J., Loonstra, A., & Berns, A. (2001) · Nature · doi:10.1038/35092584 · Cited by 568 · cited 1×
“…carcinoma Familial melanoma, sporadic pancreatic, brain tumours Crossed with Arf+/ mice Metastatic melanoma, sarcoma, carcinoma, lymphoma (Krimpenfort et al, 2001) Brca1 No tumour susceptibility Breast ovary Conditional mammaryspecific inactivation of Brca1 Mammary tumours (Xu et al,…”
BackgroundTrends in cancer incidence and mortality in Scotland: description and possible explanations
Swerdlow, A., dos Santos Silva, I., Reid, A., Qiao, Z., Brewster, D., & Arrundale, J. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.424 · Cited by 532
A census of amplified and overexpressed human cancer genes
Santarius, T., Shipley, J., Brewer, D., Stratton, M. R., & Cooper, C. S. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2771 · Cited by 482
Politi, K., Zakowski, M. F., Fan, P.-D., Schonfeld, E. A., Pao, W., & Varmus, H. E. (2006) · Genes & Development · doi:10.1101/gad.1417406 · Cited by 478 · cited 1×
“…tumorigenicity and metastatic capacity, and some studies have shown that mouse cancer models with relevant human gene mutations respond to appropriate targeted therapies (Politi et al, 2006), and also may develop common secondary mutations associated with acquired resistance (Politi et al, 2010).”
BackgroundShort tandem repeat profiling provides an international reference standard for human cell lines
Masters, J. R., Thomson, J. A., Daly-Burns, B., Reid, Y. A., Dirks, W. G., Packer, P., Toji, L. H., Ohno, T., Tanabe, H., Arlett, C. F., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121616198 · Cited by 478 · cited 1×
“…genetic characterisation, facilitated by modern high-throughput technologies (e.g., see http://www.sanger.ac.uk/genetics/CGP), is now available for human cancer cell lines used for xenografts (Masters et al, 2001; Park et al, 2010) and is important to understand the biology of these models and to…”
BackgroundReversible Activation of c-Myc in Skin
Pelengaris, S., Littlewood, T., Khan, M., Elia, G., & Evan, G. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80350-0 · Cited by 468
New approaches for imaging tumour responses to treatment
Brindle, K. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2289 · Cited by 460
Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects
Reilly, K. M., Loisel, D. A., Bronson, R. T., McLaughlin, M. E., & Jacks, T. (2000) · Nature Genetics · doi:10.1038/79075 · Cited by 425
High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+/- mice.
Stambolic, V., Tsao, M., MacPherson, D. P., Suzuki, A., Chapman, W. B., & Mak, T. W. (2000) · PubMed · Cited by 414
New approaches to molecular cancer therapeutics
Collins, I., & Workman, P. (2006) · Nature Chemical Biology · doi:10.1038/nchembio840 · Cited by 391
Self-citationLoss of p53 but not ARF accelerates medulloblastoma in mice heterozygous for patched.
Wetmore, C., Eberhart, D. E., & Curran, T. (2001) · PubMed · Cited by 390
The pathological response to DNA damage does not contribute to p53-mediated tumour suppression
Christophorou, M. A., Ringshausen, I., Finch, A. J., Swigart, L. B., & Evan, G. I. (2006) · Nature · doi:10.1038/nature05077 · Cited by 382
Giovannini, M., Robanus-Maandag, E., van der Valk, M., Niwa-Kawakita, M., Abramowski, V., Goutebroze, L., Woodruff, J. M., Berns, A., & Thomas, G. (2000) · Genes & Development · doi:10.1101/gad.14.13.1617 · Cited by 369
Kelland, L. R. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2003.11.028 · Cited by 352
Bruns, C. J., Harbison, M. T., Kuniyasu, H., Eue, I., & Fidler, I. J. (1999) · Neoplasia · doi:10.1038/sj.neo.7900005 · Cited by 350
Contributions of Human Tumor Xenografts to Anticancer Drug Development
Sausville, E. A., & Burger, A. M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3627 · Cited by 348
Paulmurugan, R., Umezawa, Y., & Gambhir, S. S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242594299 · Cited by 334
p107 is a suppressor of retinoblastoma development in pRb-deficient mice
Robanus-Maandag, E., Dekker, M., van der Valk, M., Carrozza, M.-L., Jeanny, J.-C., Dannenberg, J.-H., Berns, A., & te Riele, H. (1998) · Genes & Development · doi:10.1101/gad.12.11.1599 · Cited by 320
Poller, B., Gutmann, H., Krähenbühl, S., Weksler, B., Romero, I., Couraud, P., Tuffin, G., Drewe, J., & Huwyler, J. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05730.x · Cited by 317
Dorsal skinfold chamber technique for intravital microscopy in nude mice.
Lehr, H., Leunig, M., Menger, M. D., Nölte, D., & Meßmer, K. (1993) · PubMed Central · Cited by 309
UKCCCR guidelines for the welfare of animals in experimental neoplasia
(1988) · Laboratory Animals · doi:10.1258/002367788780746467 · Cited by 308
Prediction of Hepatic Clearance from Microsomes, Hepatocytes, and Liver Slices
Brian Houston, J., & Carlile, D. J. (1997) · Drug Metabolism Reviews · doi:10.3109/03602539709002237 · Cited by 306
Preclinical Pharmacokinetics: An Approach Towards Safer and Efficacious Drugs
Singh, S. (2006) · Current Drug Metabolism · doi:10.2174/138920006775541552 · Cited by 293
Chen, D., Livne-bar, I., Vanderluit, J. L., Slack, R. S., Agochiya, M., & Bremner, R. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.05.025 · Cited by 281
Mouse models of human AML accurately predict chemotherapy response
Zuber, J., Radtke, I., Pardee, T. S., Zhao, Z., Rappaport, A. R., Luo, W., McCurrach, M. E., Yang, M.-M., Dolan, M. E., Kogan, S. C., et al. (2009) · Genes & Development · doi:10.1101/gad.1771409 · Cited by 279
Ihle, N. T., Lemos, R., Wipf, P., Yacoub, A., Mitchell, C., Siwak, D., Mills, G. B., Dent, P., Kirkpatrick, D. L., & Powis, G. (2009) · Cancer Research · doi:10.1158/0008-5472.can-07-6656 · Cited by 274
Barfield, M., Spooner, N., Lad, R., Parry, S., & Fowles, S. (2008) · Journal of Chromatography B · doi:10.1016/j.jchromb.2008.05.025 · Cited by 273
Corpet, D. E., & Pierre, F. H. F. (2003) · PubMed · Cited by 264
Refining procedures for the administration of substances
Morton, D. B., Jennings, M., Buckwell, A., Ewbank, R., Godfrey, C., Holgate, B., Inglis, I., James, R., Page, C., Sharman, I., et al. (2001) · Laboratory Animals · doi:10.1258/0023677011911345 · Cited by 251
Lifsted, T. Q., Voyer, T. L., Williams, M., Muller, W. J., Klein–Szanto, A. J., Buetow, K. H., & Hunter, K. W. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980812)77:4<640::aid-ijc26>3.0.co;2-8 · Cited by 244
Genetically Engineered Models Have Advantages over Xenografts for Preclinical Studies
Becher, O. J., & Holland, E. C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3827 · Cited by 243
Liem, N. L. M., Papa, R. A., Milross, C. G., Schmid, M. A., Tajbakhsh, M., Choi, S., Ramirez, C. D., Rice, A. M., Haber, M., Norris, M. D., et al. (2004) · Blood · doi:10.1182/blood-2003-08-2911 · Cited by 238
Procedure for minimizing stress for fMRI studies in conscious rats
King, J. A., Garelick, T. S., Brevard, M. E., Chen, W., Messenger, T. L., Duong, T. Q., & Ferris, C. F. (2005) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2005.04.011 · Cited by 227
Advancing animal models of neoplasia through in vivo bioluminescence imaging
Edinger, M., Cao, Y.-A., Hornig, Y. S., Jenkins, D. E., Verneris, M. R., Bachmann, M. H., Negrin, R. S., & Contag, C. H. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00410-0 · Cited by 210
Small-Animal X-ray Dose from Micro-CT
Boone, J. M., Velazquez, O., & Cherry, S. R. (2004) · Molecular Imaging · doi:10.1162/15353500200404118 · Cited by 201
Ottaviani, G., Martel, S., & Carrupt, P.-A. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060230+ · Cited by 194
Dong, X., Guan, J., English, J. C., Flint, J., Yee, J., Evans, K., Murray, N., MacAulay, C., Ng, R. T., Gout, P. W., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2878 · Cited by 188
Workman, P., Aboagye, E. O., Chung, Y.-L., Griffiths, J. R., Hart, R., Leach, M. O., Maxwell, R. J., McSheehy, P. M. J., Price, P. M., & Zweit, J. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj162 · Cited by 188
Self-citationTemporal dissection of p53 function in vitro and in vivo
Christophorou, M. A., Martin-Zanca, D., Soucek, L., Lawlor, E. R., Brown-Swigart, L., Verschuren, E. W., & Evan, G. I. (2005) · Nature Genetics · doi:10.1038/ng1572 · Cited by 184
Richardson, C. A., & Flecknell, P. A. (2005) · Alternatives to Laboratory Animals · doi:10.1177/026119290503300207 · Cited by 179
Yang, L., Mao, H., Cao, Z., Wang, Y. A., Peng, X., Wang, X., Sajja, H. K., Wang, L., Duan, H., Ni, C., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.01.006 · Cited by 173
Nguyen, Q.-D., Smith, G., Glaser, M., Perumal, M., Årstad, E., & Aboagye, E. O. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901310106 · Cited by 166
Self-citationBanerji, U., Walton, M., Raynaud, F., Grimshaw, R., Kelland, L., Valenti, M., Judson, I., & Workman, P. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0518 · Cited by 164
Self-citationEffects of Rapamycin in the Eker Rat Model of Tuberous Sclerosis Complex
Kenerson, H., Dundon, T. A., & Yeung, R. S. (2005) · Pediatric Research · doi:10.1203/01.pdr.0000147727.78571.07 · Cited by 162
Persistent use of “false” cell lines
Lacroix, M. (2008) · International Journal of Cancer · doi:10.1002/ijc.23233 · Cited by 151 · cited 2×
“Cell line verification and molecular characterisation Given the frequency of misidentification and cross-contamination (Nardone, 2007; Lacroix, 2008) it is essential that all cell lines are rigorously checked for their provenance and genetic identity (Parodi et al, 2002; Yoshino et al, 2006).”
BackgroundRubio‐Viqueira, B., & Hidalgo, M. M. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.200 · Cited by 149
Noël, A., Pauw-Gillet, M. C. D., Purnell, G., Nusgens, B., LAPIERE, C. H. M., & Foidart, J. M. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.453 · Cited by 143
Festing, M., Overend, P., Das, R., Cortina‐Borja, M., & Berdoy, M. (2002) · Cited by 140
Eradication of cross-contaminated cell lines: A call for action
Nardone, R. M. (2007) · Cell Biology and Toxicology · doi:10.1007/s10565-007-9019-9 · Cited by 134
Yang, M., Reynoso, J., Jiang, P., Li, L., Moossa, A. R., & Hoffman, R. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-3118 · Cited by 134
West, C., & Price, P. (2004) · Anti-Cancer Drugs · doi:10.1097/00001813-200403000-00001 · Cited by 129
Golay, J., Cittera, E., Gaetano, N. D., Manganini, M., Mosca, M., Nebuloni, M., van Rooijen, N., Vago, L., & Introna, M. (2006) · PubMed · Cited by 129
Reactivating HIF prolyl hydroxylases under hypoxia results in metabolic catastrophe and cell death
Tennant, D. A., Frezza, C., MacKenzie, E. D., Nguyen, Q., Zheng, L., Selak, M. A., Roberts, D. L., Dive, C., Watson, D. G., Aboagye, E. O., et al. (2009) · Oncogene · doi:10.1038/onc.2009.250 · Cited by 129
Self-citationChen, X., Yang, G., Ding, W. Y., Bondoc, F. Y., Curtis, S. K., & Yang, C. S. (1999) · Carcinogenesis · doi:10.1093/carcin/20.9.1801 · Cited by 126
Molecular Characterization of the Pediatric Preclinical Testing Panel
Neale, G. A. M., Su, X., Morton, C. L., Phelps, D. A., Gorlick, R. G., Lock, R. B., Reynolds, C. P., Maris, J. M., Friedman, H. S., Dome, J. S., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-5090 · Cited by 125
Analgesia from a veterinary perspective
Flecknell, P. A. (2008) · British Journal of Anaesthesia · doi:10.1093/bja/aen087 · Cited by 117
Masimirembwa, C. M., Thompson, R., & Andersson, T. (2001) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207013331101 · Cited by 113
Verheul, H. M. W., Hammers, H. J., van Erp, K., Wei, Y., Sanni, T. B., Salumbides, B. C., Qian, D. Z., Yancopoulos, G. D., & Пили, Р. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2553 · Cited by 113
Nakai, M., Mundy, G. R., Williams, P. J., Boyce, B. F., & Yoneda, T. (1992) · PubMed · Cited by 109
Prevention of hepatic metastasis of human colon cancer by angiogenesis inhibitor TNP-470.
Tanaka, T., Konno, H., Matsuda, I., et al. (1995) · PubMed · Cited by 105
Mitra, S. K., Lim, S.-T., Chi, A., & Schlaepfer, D. D. (2006) · Oncogene · doi:10.1038/sj.onc.1209482 · Cited by 103
Radaelli, E., Ceruti, R., Patton, V., Russo, M., Degrassi, A., Croci, V., Caprera, F., Stortini, G., Scanziani, E., Pesenti, E. A., et al. (2009) · PubMed · doi:10.14670/hh-24.879 · Cited by 101
Jackson, I. L., Vujašković, Ž., & Down, J. D. (2009) · Radiation Research · doi:10.1667/rr1911.1 · Cited by 101
Park, E. S., Rabinovsky, R., Carey, M. S., Hennessy, B. T., Agarwal, R., Liu, W., Ju, Z., Deng, W., Lu, Y., Woo, H. G., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0743 · Cited by 99
Evaluation of saphenous venipuncture and modified tail-clip blood collection in mice.
Abatan, O. I., Welch, K. B., & Nemzek, J. A. (2008) · PubMed · Cited by 98
Hirose, Y., Hata, K., Kuno, T., Yoshida, K., Sakata, K., Yamada, Y., Tanaka, T., Reddy, B. S., & Mori, H. (2003) · Carcinogenesis · doi:10.1093/carcin/bgh059 · Cited by 98
Species Identification and Confirmation of Human and Animal Cell Lines: A PCR-Based Method
Parodi, B., Aresu, O., Bini, D., Lorenzini, R., Schena, F., Visconti, P., Cesaro, M., Ferrera, D., Andreotti, V., & Ruzzon, T. (2002) · BioTechniques · doi:10.2144/02322rr05 · Cited by 97
Siim, B. G., Lee, A., Shalal-Zwain, S., Pruijn, F. B., McKeage, M. J., & Wilson, W. R. (2003) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-002-0529-0 · Cited by 95
Effect of Clomiphene on the Uptake of Estradiol by the Anterior Hypothalamus and Hypophysis
Kato, J., Kobayashi, T., & Villee, C. A. (1968) · Endocrinology · doi:10.1210/endo-82-5-1049 · Cited by 94
Becker, J. C., Pancook, J. D., Gillies, S. D., Mendelsohn, J. M., & Reisfeld, R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.7.2702 · Cited by 91
Viable circulating metastatic cells produced in orthotopic but not ectopic prostate cancer models.
Glinskii, A. B., Smith, B. A., Jiang, P., et al. (2003) · PubMed · Cited by 91
Erlotinib resistance in mouse models of epidermal growth factor receptor-induced lung adenocarcinoma
Politi, K. A., Fan, P., Shen, R., Zakowski, M. F., & VARMUS, H. E. (2009) · Disease Models & Mechanisms · doi:10.1242/dmm.003681 · Cited by 88
Journal Editorial Policies, Animal Welfare, and the 3Rs
Osborne, N. J., Payne, D., & Newman, M. L. (2009) · The American Journal of Bioethics · doi:10.1080/15265160903318343 · Cited by 86
Mouse models of gastrointestinal tumors
Taketo, M. M. (2006) · Cancer Science · doi:10.1111/j.1349-7006.2006.00190.x · Cited by 81
PCR-based detection of Mycoplasma species.
Sung, H., Kang, S. H., Bae, Y. J., Hong, J. T., Chung, Y. B., Lee, C., & Song, S. (2006) · PubMed · Cited by 80
Microregional Effects of Gemcitabine in HCT-116 Xenografts
Huxham, L. A., Kyle, A. H., Baker, J. H. E., Nykilchuk, L. K., & Minchinton, A. I. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0986 · Cited by 79
Smith, N. F., Raynaud, F. I., & Workman, P. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0324 · Cited by 78
Self-citationMcCann, C. M., Waterman, P. R., Figueiredo, J., Aikawa, E. R., Weissleder, R., & Chen, J. W. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.12.022 · Cited by 74
Radioimmunotherapy of micrometastases in lung with vascular targeted213Bi
Kennel, S. J., Boll, R. A., Stabin, M. G., Schuller, H. M., & Mirzadeh, S. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690337 · Cited by 70
Bruneau, P., & McElroy, N. R. (2005) · Journal of Chemical Information and Modeling · doi:10.1021/ci0504014 · Cited by 68
Qian, C., Furge, K. A., Knol, J., Huang, D., Chen, J., Dykema, K. J., Kort, E. J., Massie, A., Khoo, S. K., Beldt, K. V., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1689 · Cited by 67
Assessing the welfare of genetically altered mice
Wells, D. J., Playle, L. C., Enser, W. E. J., Flecknell, P. A., Gardiner, M. A., Holland, J., Howard, B. R., Hubrecht, R. C., Humphreys, K., Jackson, I. J., et al. (2006) · Laboratory Animals · doi:10.1258/002367706776318971 · Cited by 66
Self-citationDickson, P. V., Hamner, J. B., Ng, C. Y., Hall, M. M., Zhou, J., Hargrove, P. W., McCarville, M. B., & Davidoff, A. M. (2007) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2007.02.027 · Cited by 65
Koehl, G. E., Gaumann, A. K. A., & Geissler, E. K. (2009) · Clinical & Experimental Metastasis · doi:10.1007/s10585-008-9234-7 · Cited by 64
Flavones as Colorectal Cancer Chemopreventive Agents—Phenol-O-Methylation Enhances Efficacy
Cai, H., Sale, S., Schmid, R., Britton, R. G., Brown, K., Steward, W. P., & Gescher, A. J. (2009) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-09-0081 · Cited by 64
Patel, S. K., Turner, P. R., Stubberfield, C. R., Barry, E., Rohlff, C., Stamps, A. C., Tyson, K. L., Terrett, J., Box, G., Eccles, S. A., et al. (2001) · International Journal of Cancer · doi:10.1002/ijc.1638 · Cited by 60
Self-citationKim, E. J., Shin, M., Park, H., Hong, J. E., Shin, H., Kim, J., Kwon, D. Y., & Park, J. H. Y. (2009) · Journal of Nutrition · doi:10.3945/jn.109.111864 · Cited by 57
Yang, W., Velcich, A., Mariadason, J. M., Nicholas, C., Corner, G. A., Houston, M. A., Edelmann, W., Kucherlapati, R., Holt, P. R., & Augenlicht, L. H. (2001) · PubMed · Cited by 57
Laser Light Scattering in Biomedical Diagnostics and Therapy
Tuchin, V. V. (1993) · Journal of Laser Applications · doi:10.2351/1.4745330 · Cited by 56
The Design and Statistical Analysis of Animal Experiments
Festing, M. F. W. (2002) · ILAR Journal · doi:10.1093/ilar.43.4.191 · Cited by 55
Varticovski, L., Hollingshead, M. G., Robles, A. I., Wu, X., CHERRY, J. P., Munroe, D. J., Lukes, L., Anver, M. R., Carter, J., Borgel, S. D., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0918 · Cited by 53
Quaglino, E., Mastini, C., Forni, G., & Cavallo, F. (2008) · Current Protocols in Immunology · doi:10.1002/0471142735.im2009s82 · Cited by 51
Welfare Issues of Genetically Modified Animals
Dennis, M. B. (2002) · ILAR Journal · doi:10.1093/ilar.43.2.100 · Cited by 51
Multimodality imaging of TGFβ signaling in breast cancer metastases
Serganova, I. S., Moroz, E., Vider, J., Gogiberidze, G., Moroz, M. A., Pillarsetty, N., Doubrovin, M., Minn, A. J., Thaler, H. T., Massagué, J., et al. (2009) · The FASEB Journal · doi:10.1096/fj.08-126920 · Cited by 51
Marcotte, R., & Muller, W. J. (2008) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-008-9087-3 · Cited by 50
Zheng, Q., Chen, X. Y., SHI, Y., & Shu Dong, X. I. A. O. (2004) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2004.03469.x · Cited by 49
Time of death of CNS tumor-bearing rats can be reliably predicted by body weight-loss patterns.
Redgate, E. S., Deutsch, M., & Boggs, S. S. (1991) · PubMed · Cited by 45
Essential role for gene profiling analysis in the authentication of human cell lines
YOSHINO, K., IIMURA, E., SAIJO, K., IWASE, S., FUKAMI, K., OHNO, T., OBATA, Y., & NAKAMURA, Y. (2006) · Human Cell · doi:10.1111/j.1749-0774.2005.00007.x · Cited by 44
MK2 regulates the early stages of skin tumor promotion
Johansen, C., Vestergaard, C., Kragballe, K., Kollias, G. A., Gaestel, M., & Iversen, L. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp238 · Cited by 44
RAPID DETECTION OF MYCOPLASMA CONTAMINATION IN CELL CULTURES USING SYBR GREEN-BASED REAL-TIME PCR
Ishikawa, Y., Kozakai, T., Morita, H., Saida, K., Oka, S., & Masuo, Y. (2006) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1290/0505035.1 · Cited by 44
The Influence of DMPK as an Integrated Partner in Modern Drug Discovery
Riley, R. J., Martin, I. J., & Cooper, A. E. (2002) · Current Drug Metabolism · doi:10.2174/1389200023337135 · Cited by 42
Tan, M. T., Fang, H.-B., Tian, G.-L., & Houghton, P. J. (2004) · Statistics in Medicine · doi:10.1002/sim.1775 · Cited by 42
EGFR Activation and Ultraviolet Light‐Induced Skin Carcinogenesis
El-Abaseri, T. B., & Hansen, L. A. (2007) · BioMed Research International · doi:10.1155/2007/97939 · Cited by 39
In Silico Prediction of Ionization Constants of Drugs
Lee, P. H., Ayyampalayam, S. N., Carreira, L. A., et al. (2007) · Molecular Pharmaceutics · doi:10.1021/mp070019+ · Cited by 39
Modeling therapy resistance in genetically engineered mouse cancer models
Rottenberg, S., & Jonkers, J. (2008) · Drug Resistance Updates · doi:10.1016/j.drup.2007.11.002 · Cited by 38
Mutations in Cancer Genes of UV-Induced Skin Tumors of Hairless Mice
van Kranen, H. J., & de Gruijl, F. R. (1999) · Journal of Epidemiology · doi:10.2188/jea.9.6sup_58 · Cited by 36
Imaging Pharmacodynamics of the α-Folate Receptor–Targeted Thymidylate Synthase Inhibitor BGC 945
Pillai, R. G., Forster, M. D., Perumal, M., Mitchell, F., Leyton, J., Aibgirhio, F. I., Golovko, O., Jackman, A. L., & Aboagye, E. O. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0135 · Cited by 34
Self-citationUrinary Retention and Cystitis Associated with Subcutaneous Estradiol Pellets in Female Nude Mice
Pearse, G., Frith, J., Randall, K. J., & Klinowska, T. C. M. (2009) · Toxicologic Pathology · doi:10.1177/0192623308329281 · Cited by 32
Ahsan, H., Aziz, M. H., & Ahmad, N. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.05.106 · Cited by 31
The Use of Non-human Animals in Research: A Guide for Scientists
Russell, W. M. S. (2004) · Alternatives to Laboratory Animals · doi:10.1177/026119290403200209 · Cited by 30
Use of hu-IgG-SCID mice to evaluate the in vivo stability of human monoclonal IgG antibodies
Bazin, R., Boucher, G., Monier, G., Chevrier, M., Verrette, S., Broly, H., & Lemieux, R. (1994) · Journal of Immunological Methods · doi:10.1016/0022-1759(94)90108-2 · Cited by 29
Interactions between microenvironment and cancer cells in two animal models of bone metastasis
Blouin, S., Baslé, M. F., & Chappard, D. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604238 · Cited by 28
Adaptation to Stress Induced by Restraining Rats and Mice in Nose-Only Inhalation Holders
Narciso, S. P., Nadziejko, E., Chen, L. C., Gordon, T., & Nadziejko, C. (2003) · Inhalation Toxicology · doi:10.1080/08958370390228592 · Cited by 28
Chan, R., Muller, W. J., & Siegel, P. M. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb08722.x · Cited by 27
Comstock, K. E., Hall, C. L., Daignault, S. D., Mandlebaum, S., Yu, C., & Keller, E. T. (2009) · PubMed · Cited by 26
Carcinogenesis related to intense pulsed light and UV exposure: an experimental animal study
Hedelund, L., Lerche, C. M., Wulf, H. C., & Hædersdal, M. (2006) · Lasers in Medical Science · doi:10.1007/s10103-006-0395-9 · Cited by 24
Initial studies on an in vivo action spectrum for melanoma induction
Fabo, E. C. D. (2006) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2006.02.024 · Cited by 23
Dennis, C. (2006) · Nature · doi:10.1038/442739a · Cited by 23
Monitoring specific T-cell responses to melanoma vaccines: ELISPOT, tetramers, and beyond
Gajewski, T. F. (2000) · Clinical Diagnostic Laboratory Immunology · doi:10.1128/cdli.7.2.141-144.2000 · Cited by 21
Reconstructing Immunity After Allogeneic Transplantation
Giver, C. R., Li, J., Hossain, M. S., Lonial, S., & Waller, E. K. (2004) · Immunologic Research · doi:10.1385/ir:29:1-3:269 · Cited by 21
Immune Response Against 3LL Lewis Lung Carcinoma Potentiates the Therapeutic Efficacy of Endostatin
Li, M., Huang, X., Zhu, Z.-Y., Wong, M. K. K., Watkins, S. C., Zhao, Q., Herberman, R. B., & Gorelik, E. (2001) · Journal of Immunotherapy · doi:10.1097/00002371-200111000-00004 · Cited by 20
Hirayama, T. T., Honda, A., Matsuzaki, Y., et al. (2006) · Hepatology · doi:10.1002/hep.21291 · Cited by 20
Mouse Modifier Genes in Mammary Tumorigenesis and Metastasis
Winter, S. F., & Hunter, K. W. (2008) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-008-9089-1 · Cited by 20
Rodríguez‐Cuesta, J., Vidal‐Vanaclocha, F., Mendoza, L., Valcárcel, M., Gallot, N., & de Tejada, G. M. (2005) · Clinical & Experimental Metastasis · doi:10.1007/s10585-005-5261-9 · Cited by 18
Graff, B. A., Benjaminsen, I. C., Melås, E. A., Brurberg, K. G., & Rofstad, E. K. (2005) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2005.09.006 · Cited by 17
Cited by
Reporting animal research: Explanation and elaboration for the ARRIVE guidelines 2.0
Percie du Sert, N., Ahluwalia, A., Alam, S., Avey, M. T., Baker, M., Browne, W. J., Clark, A., Cuthill, I. C., Dirnagl, U., Emerson, M., et al. (2020) · PLOS Biology · doi:10.1371/journal.pbio.3000411 · Cited by 2,677
“, tumour size in cancer studies [50], sensorymotor deficits in stroke studies [220]).”
BackgroundPatient-derived organoids model treatment response of metastatic gastrointestinal cancers
Vlachogiannis, G., Hedayat, S., Vatsiou, A., Jamin, Y., Fernández-Mateos, J., Khan, K., Lampis, A., Eason, K., Huntingford, I., Burke, R., et al. (2018) · Science · doi:10.1126/science.aao2774 · Cited by 2,096
Self-citationCombinatorial drug therapy for cancer in the post-genomic era
Al-Lazikani, B., Banerji, U., & Workman, P. (2012) · Nature Biotechnology · doi:10.1038/nbt.2284 · Cited by 1,070
Self-citationImaging biomarker roadmap for cancer studies
O'Connor, J. P. B., Aboagye, E. O., Adams, J. E., Aerts, H. J. W. L., Barrington, S. F., Beer, A. J., Boellaard, R., Bohndiek, S. E., Brady, M., Brown, G., et al. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.162 · Cited by 1,091
Self-citationDiscovery of small molecule cancer drugs: Successes, challenges and opportunities
Hoelder, S., Clarke, P. A., & Workman, P. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.02.004 · Cited by 587
Self-citation
Metadata
- Authors
- An ad hoc committee of the National Cancer Research Institute, Workman, P., Aboagye, E. O., Balkwill, F., Balmain, A., Bruder, G., Chaplin, D. J., Double, J. A., Everitt, J., Farningham, D. A. H., Glennie, M. J., Kelland, L. R., Robinson, V, Stratford, I. J., Tozer, G. M., Watson, S., Wedge, S. R., & Eccles, S. A.
- Venue
- British Journal of Cancer
- Published
- 2010-05
- Volume
- 102
- Issue
- 11
- Pages
- 1555-1577
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2115785123
- Cited by
- 1,442
- References
- 162
- FWCI
- 113.50
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.